XORTX Therapeutics Inc. (XRTX) Q2 2024 Earnings
XRTX·Reported August 14, 2024·After market close
Diluted EPS came in at $0.06, beat the $-0.50 consensus by $0.56.
Diluted EPS
$0.06beat by $0.56
Consensus: $-0.50
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about XORTX Therapeutics Inc.'s Q2 2024 earnings report.
XORTX Therapeutics Inc. (XRTX) reported Q2 2024 earnings on August 14, 2024 after market close.
XORTX Therapeutics Inc. reported diluted EPS of $0.06 for Q2 2024.
EPS beat the consensus estimate of $-0.50 by $0.56.